Cancer chemotherapy and biotherapy : principles and practice /

Mostrar otras versiones (1)

"Updated to include the newest drugs and those currently in development, Cancer Chemotherapy and Biotherapy, Fifth Edition is a comprehensive reference on the preclinical and clinical pharmacology of anticancer agents. Organized by drug class, the book provides the latest information on all dru...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Otros Autores: Chabner, Bruce, Longo, Dan L. (Dan Louis), 1949-
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Philadelphia : Wolters Kluwer Health/Lippincott Williams & Wilkins, ©2011.
Edición:5th ed.
Temas:
Cancer > Chemotherapy.
Cancer > Immunotherapy.
Antineoplastic agents.
Biological response modifiers.
Neoplasms > drug therapy
Antineoplastic Agents > therapeutic use
Biological Factors > therapeutic use
Immunologic Factors
Biological Products > therapeutic use
Cancer > Chimiothérapie.
Cancer > Immunothérapie.
Anticancéreux.
Immunomodulateurs.
Antineoplastic agents
Biological response modifiers
Cancer > Chemotherapy
Cancer > Immunotherapy
Internet Resources.
Acceso en línea:Texto completo
Tabla de Contenidos:
  • Clinical strategies for cancer treatment: the role of drugs
  • Target identification and drug discovery
  • Clinical drug development and marketing approval
  • Principles of pharmacokinetics
  • Delivering anticancer drugs to brain tumors
  • Pharmacogenetics
  • Physical barriers to drug delivery
  • Antifolates
  • 5-fluoropyrimidines
  • Cytidine analogues
  • Purine antimetabolites
  • Hydroxyurea
  • Antimitotic drugs
  • Alkylating agents
  • Platinum analogues
  • Bleomycin and other antitumor antibiotics
  • Topoisomerase I-targeting drugs
  • Topoisomerase II inhibitors: anthracyclines
  • Topoisomerase II inhibitors: the epipodophyllotoxins
  • Asparaginase
  • Proteasome inhibitors
  • Histone deacetylase inhibitors in oncology
  • Differentiating agents
  • Arsenic trioxide
  • Antibodies
  • Inhibitors of tumor angiogenesis
  • Epidermal growth factor receptor inhibitors
  • HER2 inhibitors
  • Molecular targeted drugs
  • Signaling inhibitors: IGFR, PI3K pathway, embryonic signaling inhibitors, and mitotic kinase inhibitors
  • Cytokine therapy for cancer
  • Cancer vaccines
  • Adoptive cellular therapies
  • Thalidomide and its analogs in the treatment of hematologic malignancies, including multiple myeloma, and solid tumors
  • Hormonal therapy of breast cancer
  • Hormone therapy for prostate cancer
  • Drug therapy of pain in cancer patients
  • Hematopoietic growth factors
  • Antinausea medications
  • Bisphosphonates and other bone-targeted therapies
  • Intravenous access and catheter management
  • Late effects of cancer chemotherapy
  • Infertility after cancer chemotherapy.

Ejemplares similares